Advanced search
Publication Cover
Leukemia & Lymphoma Volume 22, 1996 - Issue sup1
Submit an article Journal homepage
34
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Current Aspects of Drug Therapy in Philadelphia-positive CML: Correlation of Tumor Burden with Survival

R. Hehlmann III. Medizinische Klinik, Klinikum Mannheim. Universität Heidelberg, Wiesbadener Str. 7-11, 68305, Mannheim, Germany
&
H. Heimpel III. Medizinische Klinik, Klinikum Mannheim. Universität Heidelberg, Wiesbadener Str. 7-11, 68305, Mannheim, Germany
Pages 161-167 | Received 18 Mar 1996, Published online: 01 Jul 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hana Bruchova, Tereza Borovanova, Hana Klamova & Radim Brdicka. (2002) Gene Expression Profiling in Chronic Myeloid Leukemia Patients Treated with Hydroxyurea. Leukemia & Lymphoma 43:6, pages 1289-1295.
Read now

Articles from other publishers (15)

Rüdiger Hehlmann. (2012) How I treat CML blast crisis. Blood 120:4, pages 737-747.
Crossref
Rüdiger HehlmannMichael LausekerSusanne Jung-MunkwitzArmin LeitnerMartin C. MüllerNadine PletschUlrike ProetelClaudia HaferlachBrigitte SchlegelbergerLeopold BalleisenMathias HänelMarkus PfirrmannStefan W. KrauseChristoph NerlHans PralleAlois GratwohlDieter K. HossfeldJoerg HasfordAndreas HochhausSusanne Saußele. (2011) Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia. Journal of Clinical Oncology 29:12, pages 1634-1642.
Crossref
Roxanna L. Gapstur. (2007) Symptom Burden: A Concept Analysis and Implications for Oncology Nurses. Oncology Nursing Forum 34:3, pages 673-680.
Crossref
M Giehl, A Fabarius, O Frank, A Hochhaus, M Hafner, R Hehlmann & W Seifarth. (2005) Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instability. Leukemia 19:7, pages 1192-1197.
Crossref
P Paschka, M C Müller, K Merx, S Kreil, C Schoch, T Lahaye, A Weisser, A Petzold, H König, U Berger, H Gschaidmeier, R Hehlmann & A Hochhaus. (2003) Molecular monitoring of response to imatinib (Glivec®) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission. Leukemia 17:9, pages 1687-1694.
Crossref
J Giron-Michel, D Weill, G Bailly, S Legras, PC Nardeux, B Azzarone, MG Tovey & P Eid. (2002) Direct signal transduction via functional interferon-αβ receptors in CD34+ hematopoietic stem cells. Leukemia 16:6, pages 1135-1142.
Crossref
Andreas Hochhaus. (2002) Minimal residual disease in chronic myeloid leukaemia patients. Best Practice & Research Clinical Haematology 15:1, pages 159-178.
Crossref
Juergen Thiele, Hans M. Kvasnicka, Annette Schmitt-Graeff, Dilek Goekce, Volker Diehl, Rudolf Zankovich & Hans E. Schaefer. (2001) Therapy-Related Changes of CD34 + Progenitor Cells in Chronic Myeloid Leukemia: A Morphometric Study on Sequential Trephine Biopsies . Journal of Hematotherapy & Stem Cell Research 10:6, pages 827-836.
Crossref
Juergen Thiele, Hans Michael Kvasnicka, Annette Schmitt-Graeff, Gabriela Cvetanovska, Nicole Blum & Hans Eckart Schaefer. (2000) Therapy-related Changes of CD20+ and CD45RO+ Lymphocyte Subsets in Chronic Myeloid Leukemia (CML): An Immunohistochemical and Morphometric Study on Sequential Trephine Biopsies of the Bone Marrow. Modern Pathology 13:8, pages 888-896.
Crossref
Juergen Thiele, Hans M. Kvasnicka, Annette Schmitt-Graeff, Susanne Bundschuh, Teresa Biermann, Gernod Roessler, Maria Wasmus, Volker Diehl, Rudolf Zankovich & Hans E. Schaefer. (2000) Effects of Chemotherapy (Busulfan-Hydroxyurea) and Interferon-Alfa on Bone Marrow Morphologic Features in Chronic Myelogenous Leukemia. American Journal of Clinical Pathology 114:1, pages 57-65.
Crossref
A Hochhaus, A Weisser, P La Rosée, M Emig, MC Müller, S Saußele, A Reiter, C Kuhn, U Berger, R Hehlmann & NCP Cross. (2000) Detection and quantification of residual disease in chronic myelogenous leukemia. Leukemia 14:6, pages 998-1005.
Crossref
Eleftheria Chr Hatzimichael & Konstantinos L Bourantas. (1999) Combination therapy with interferon-alpha-2b and hydroxyurea in patients with chronic myelogenous leukemia. European Journal of Internal Medicine 10:1, pages 27-31.
Crossref
Oliver M Trapp, Maria K Beykirch & Petro E Petrides. (1998) Anagrelide for Treatment of Patients with Chronic Myelogenous Leukemia and a High Platelet Count. Blood Cells, Molecules, and Diseases 24:1, pages 9-13.
Crossref
R. Hehlmann, A. Hochhaus, U. Berger, H. Skladny & J. Hasford. 1998. Acute Leukemias VII. Acute Leukemias VII 1169 1177 .
R. Hehlmann & A. Reiter. 1997. Interferons. Interferons 47 66 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.